Under the National Tuberculosis Elimination Programme (NTEP), the current treatment regimen for drug-sensitive TB in adults (Category I) consists of:
- A 2HRZES/1HRZE/5HRE
- B 2HRZE/4HR (fixed-dose combination) ✓
- C 2HRZ/4HR
- D 6HRE/4HR
Correct answer: B. 2HRZE/4HR (fixed-dose combination)
Explanation
Under the NTEP (formerly RNTCP), drug-sensitive TB is treated with daily fixed-dose combination therapy: 2 months of Intensive Phase (HRZE — Isoniazid, Rifampicin, Pyrazinamide, Ethambutol) followed by 4 months of Continuation Phase (HR — Isoniazid and Rifampicin), denoted 2HRZE/4HR. The earlier Category I/II distinction has been replaced with a single regimen for all new and previously treated drug-sensitive cases.
Reference: Park's Textbook of Preventive and Social Medicine, 27th ed.
High-yield for: NEET PGINI-CETNExTFMGEUSMLEPLABMRCP
Written and medically reviewed by the StethoPrep medical team.